Robert Aiken

2.7k total citations
36 papers, 575 citations indexed

About

Robert Aiken is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Robert Aiken has authored 36 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 13 papers in Immunology and 11 papers in Oncology. Recurrent topics in Robert Aiken's work include Glioma Diagnosis and Treatment (21 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Research and Treatments (7 papers). Robert Aiken is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Immunotherapy and Immune Responses (12 papers) and Cancer Research and Treatments (7 papers). Robert Aiken collaborates with scholars based in United States, Netherlands and India. Robert Aiken's co-authors include Mark Curtis, Renato Baserga, Mariana Resnicoff, George Iliakis, Adam E. Flanders, David W. Andrews, Lawrence C. Kenyon, Simon Hanft, Amanda Carpenter and Austin B. Carpenter and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Aiken

34 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Aiken United States 14 224 203 193 120 119 36 575
Naheed Gul United States 7 401 1.8× 192 0.9× 373 1.9× 48 0.4× 231 1.9× 11 790
Sameer A. Greenall Australia 13 203 0.9× 125 0.6× 142 0.7× 43 0.4× 91 0.8× 22 424
Maxim Kebenko Germany 12 243 1.1× 62 0.3× 265 1.4× 165 1.4× 43 0.4× 30 609
Jorge DiMartino United States 14 829 3.7× 140 0.7× 217 1.1× 117 1.0× 88 0.7× 42 1.2k
Megan Kaba United States 4 281 1.3× 180 0.9× 148 0.8× 112 0.9× 137 1.2× 4 675
Sagi Abelson Canada 12 520 2.3× 82 0.4× 204 1.1× 176 1.5× 213 1.8× 27 866
Stephan Seitz Germany 14 155 0.7× 28 0.1× 216 1.1× 40 0.3× 77 0.6× 44 512
A.M. Vénuat France 12 262 1.2× 93 0.5× 148 0.8× 97 0.8× 56 0.5× 20 526
Marta Doménech Spain 11 165 0.7× 113 0.6× 140 0.7× 60 0.5× 127 1.1× 31 410
Philip E. Boulais United States 9 230 1.0× 158 0.8× 185 1.0× 237 2.0× 45 0.4× 15 643

Countries citing papers authored by Robert Aiken

Since Specialization
Citations

This map shows the geographic impact of Robert Aiken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Aiken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Aiken more than expected).

Fields of papers citing papers by Robert Aiken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Aiken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Aiken. The network helps show where Robert Aiken may publish in the future.

Co-authorship network of co-authors of Robert Aiken

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Aiken. A scholar is included among the top collaborators of Robert Aiken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Aiken. Robert Aiken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bota, Daniela A., David Piccioni, Christopher Duma, et al.. (2025). Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Human Vaccines & Immunotherapeutics. 21(1). 2556591–2556591.
2.
Ahluwalia, Manmeet S., Michael J. Ciesielski, David A. Reardon, et al.. (2024). A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).. Journal of Clinical Oncology. 42(16_suppl). TPS2099–TPS2099. 4 indexed citations
3.
Bota, Daniela A., David Piccioni, Thomas H. Taylor, et al.. (2023). Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 41(16_suppl). 2047–2047. 1 indexed citations
4.
Bota, Daniela A., Thomas H. Taylor, David Piccioni, et al.. (2022). Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment. Journal of Experimental & Clinical Cancer Research. 41(1). 344–344. 38 indexed citations
5.
Reardon, David A., Steven Brem, Arati Desai, et al.. (2022). Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2004–2004. 19 indexed citations
6.
Pamarthy, Sahithi, Liqiong Liu, Robert Aiken, et al.. (2021). Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening. STAR Protocols. 2(1). 100345–100345. 10 indexed citations
7.
Carpenter, Austin B., Amanda Carpenter, Robert Aiken, & Simon Hanft. (2021). Oncolytic virus in gliomas: a review of human clinical investigations. Annals of Oncology. 32(8). 968–982. 39 indexed citations
8.
Patel, Nitesh V., et al.. (2021). Leptomeningeal disease in glioblastoma: endgame or opportunity?. Journal of Neuro-Oncology. 155(2). 107–115. 14 indexed citations
9.
Bota, Daniela A., David Piccioni, Christopher Duma, et al.. (2021). CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1). Neuro-Oncology. 23(Supplement_6). vi58–vi58. 1 indexed citations
10.
Kim, Michelle M., Hemant Parmar, Matthew J. Schipper, et al.. (2020). BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 107(3). 478–486. 10 indexed citations
11.
Stein, Mark N., Nancy Chan, Ann W. Silk, et al.. (2017). Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients.. Journal of Clinical Oncology. 35(15_suppl). 2586–2586. 1 indexed citations
12.
13.
Aiken, Robert. (2014). Molecular Neuro-oncology and the Challenge of the Blood-Brain Barrier. Seminars in Oncology. 41(4). 438–445. 11 indexed citations
14.
Grossmann, Kenneth F., Howard Colman, Wallace Akerley, et al.. (2012). Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. Journal of Neuro-Oncology. 110(2). 257–264. 29 indexed citations
15.
Hawkins, Elma S., Robert Aiken, James R. Chandler, et al.. (2012). A randomized, double‑blind, controlled phase IIb study of the safety and efficacy of ICT‑107 in newly diagnosed patients with glioblastoma multiforme following resection and chemoradiation.. Journal of Clinical Oncology. 30(15_suppl). TPS2107–TPS2107. 2 indexed citations
16.
Holmes, Douglas, et al.. (2011). Abstract 13330: Steam Pop Prediction and Detection During Radiofrequency Ablation. Circulation. 124. 1 indexed citations
17.
Aiken, Robert. (2006). Neurologic Complications of Head and Neck Cancers. Seminars in Oncology. 33(3). 348–351. 3 indexed citations
18.
Aiken, Robert. (1994). Quality-of-life issues in patients with malignant gliomas.. PubMed. 21(2). 273–5. 32 indexed citations
19.
McGinley, Patton H., Elizabeth K. Butker, Ian Crocker, & Robert Aiken. (1992). An adjustable collimator for stereotactic radiosurgery. Physics in Medicine and Biology. 37(2). 413–419. 16 indexed citations
20.
Caldwell, John R., M. Anthony Schork, & Robert Aiken. (1978). Is near basal blood pressure a more accurate predictor of cardiorenal manifestations of hypertension than casual blood pressure?. Journal of Chronic Diseases. 31(8). 507–512. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naheed Gul Breakdown of academic impact, for papers by Sameer A. Greenall Breakdown of academic impact, for papers by Maxim Kebenko Breakdown of academic impact, for papers by Jorge DiMartino Breakdown of academic impact, for papers by Megan Kaba Breakdown of academic impact, for papers by Sagi Abelson Breakdown of academic impact, for papers by Stephan Seitz Breakdown of academic impact, for papers by A.M. Vénuat Breakdown of academic impact, for papers by Marta Doménech Breakdown of academic impact, for papers by Philip E. Boulais
Rankless by CCL
2026